Olema Pharmaceuticals Inc...

3.32
-0.03 (-0.90%)
At close: Apr 04, 2025, 11:08 AM

Olema Pharmaceuticals Statistics

Share Statistics

Olema Pharmaceuticals has 68.33M shares outstanding. The number of shares has increased by 22.17% in one year.

Shares Outstanding 68.33M
Shares Change (YoY) 22.17%
Shares Change (QoQ) 19.26%
Owned by Institutions (%) 99.99%
Shares Floating 54.63M
Failed to Deliver (FTD) Shares 17.59K
FTD / Avg. Volume 1.65%

Short Selling Information

The latest short interest is 10.87M, so 15.91% of the outstanding shares have been sold short.

Short Interest 10.87M
Short % of Shares Out 15.91%
Short % of Float 20.23%
Short Ratio (days to cover) 8.38

Valuation Ratios

The PE ratio is -2.65 and the forward PE ratio is -2.28. Olema Pharmaceuticals's PEG ratio is -0.94.

PE Ratio -2.65
Forward PE -2.28
PS Ratio 0
Forward PS 0.7
PB Ratio 0.84
P/FCF Ratio -3.28
PEG Ratio -0.94
Financial Ratio History

Enterprise Valuation

Currently the Enterprise Value (EV) is not available for Olema Pharmaceuticals.

EV / Sales n/a
EV / EBITDA n/a
EV / EBIT n/a
EV / FCF n/a

Financial Position

The company has a current ratio of 10.5, with a Debt / Equity ratio of 0.

Current Ratio 10.5
Quick Ratio 10.5
Debt / Equity 0
Debt / EBITDA -0.01
Debt / FCF -0.01
Interest Coverage 0

Financial Efficiency

Return on Equity is n/a and Return on Invested Capital is n/a.

Return on Equity n/a
Return on Assets n/a
Return on Invested Capital n/a
Revenue Per Employee $0
Profits Per Employee $-1.35M
Employee Count 96
Asset Turnover 0
Inventory Turnover n/a

Taxes

Income Tax 0
Effective Tax Rate 0%

Stock Price Statistics

The stock price has increased by -68.13% in the last 52 weeks. The beta is 2.12, so Olema Pharmaceuticals's price volatility has been higher than the market average.

Beta 2.12
52-Week Price Change -68.13%
50-Day Moving Average 4.82
200-Day Moving Average 9.36
Relative Strength Index (RSI) 25.61
Average Volume (20 Days) 1.06M

Income Statement

Revenue n/a
Gross Profit 0
Operating Income -142.26M
Net Income -129.47M
EBITDA -142.26M
EBIT n/a
Earnings Per Share (EPS) -2.2
Full Income Statement

Balance Sheet

The company has 139.48M in cash and 1.43M in debt, giving a net cash position of 138.05M.

Cash & Cash Equivalents 139.48M
Total Debt 1.43M
Net Cash 138.05M
Retained Earnings -435.11M
Total Assets 450.98M
Working Capital 396.71M
Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was -104.35M and capital expenditures 0, giving a free cash flow of -104.35M.

Operating Cash Flow -104.35M
Capital Expenditures 0
Free Cash Flow -104.35M
FCF Per Share -1.78
Full Cash Flow Statement

Margins

Gross Margin n/a
Operating Margin n/a
Pretax Margin n/a
Profit Margin n/a
EBITDA Margin n/a
EBIT Margin n/a
FCF Margin n/a

Dividends & Yields

OLMA does not appear to pay any dividends at this time.

Dividend Per Share n/a
Dividend Yield n/a
Dividend Growth (YoY) n/a
Payout Ratio n/a
Earnings Yield n/a
FCF Yield n/a
Dividend Details

Analyst Forecast

The average price target for OLMA is $28, which is 735.8% higher than the current price. The consensus rating is "Buy".

Price Target $28
Price Target Difference 735.8%
Analyst Consensus Buy
Analyst Count 3
Stock Forecasts

Scores

Altman Z-Score 1.92
Piotroski F-Score 1